DE602005005454D1 - Behandlung von Einschlusskörper-Myositis - Google Patents
Behandlung von Einschlusskörper-MyositisInfo
- Publication number
- DE602005005454D1 DE602005005454D1 DE602005005454T DE602005005454T DE602005005454D1 DE 602005005454 D1 DE602005005454 D1 DE 602005005454D1 DE 602005005454 T DE602005005454 T DE 602005005454T DE 602005005454 T DE602005005454 T DE 602005005454T DE 602005005454 D1 DE602005005454 D1 DE 602005005454D1
- Authority
- DE
- Germany
- Prior art keywords
- inclusion body
- body myositis
- treatment
- ibm
- myositis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000008319 inclusion body myositis Diseases 0.000 title abstract 5
- 208000021642 Muscular disease Diseases 0.000 abstract 1
- 201000009623 Myopathy Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Glass Compositions (AREA)
- Crushing And Grinding (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05008993A EP1716887B1 (de) | 2005-04-25 | 2005-04-25 | Behandlung von Einschlusskörper-Myositis |
Publications (2)
Publication Number | Publication Date |
---|---|
DE602005005454D1 true DE602005005454D1 (de) | 2008-04-30 |
DE602005005454T2 DE602005005454T2 (de) | 2009-04-30 |
Family
ID=34935670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005005454T Expired - Fee Related DE602005005454T2 (de) | 2005-04-25 | 2005-04-25 | Behandlung von Einschlusskörper-Myositis |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080221019A1 (de) |
EP (1) | EP1716887B1 (de) |
AT (1) | ATE389439T1 (de) |
DE (1) | DE602005005454T2 (de) |
WO (1) | WO2006115448A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012154933A1 (en) | 2011-05-10 | 2012-11-15 | The Brigham And Women's Hospital, Inc. | Detecting inclusion body myositis |
US20140221233A1 (en) | 2011-07-07 | 2014-08-07 | Stichting Katholieke Universiteit | Myositis |
EP3033622A4 (de) * | 2013-08-13 | 2017-05-31 | The Brigham and Women's Hospital, Inc. | Sensitiver diagnostischer test für einschlusskörpermyositis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103748A (en) * | 1998-06-19 | 2000-08-15 | Bryan; Thomas B. | Method of treating an autoimmune disorder |
WO2002102412A2 (en) * | 2001-06-18 | 2002-12-27 | Mcgill University | Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons |
US20040259784A1 (en) * | 2003-06-18 | 2004-12-23 | White Hillary D. | Compositions and methods for treatment of muscle pain and muscle wasting |
-
2005
- 2005-04-25 EP EP05008993A patent/EP1716887B1/de active Active
- 2005-04-25 DE DE602005005454T patent/DE602005005454T2/de not_active Expired - Fee Related
- 2005-04-25 AT AT05008993T patent/ATE389439T1/de not_active IP Right Cessation
-
2006
- 2006-04-24 US US11/909,787 patent/US20080221019A1/en not_active Abandoned
- 2006-04-24 WO PCT/SE2006/000472 patent/WO2006115448A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP1716887B1 (de) | 2008-03-19 |
US20080221019A1 (en) | 2008-09-11 |
DE602005005454T2 (de) | 2009-04-30 |
WO2006115448A1 (en) | 2006-11-02 |
ATE389439T1 (de) | 2008-04-15 |
EP1716887A1 (de) | 2006-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119488T1 (el) | Παραγων για θεραπεια ή/και αποτροπη διαταραχης υπνου | |
EA200701845A1 (ru) | Рофлумиласт для лечения сахарного диабета | |
EA200601553A1 (ru) | Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды | |
EA200900392A1 (ru) | Комбинированное лечение сахарного диабета | |
NO20061479L (no) | Anvendelse av modifiserte cyklosporiner for behandling av HCV-forstyrrelser | |
EA200601552A1 (ru) | Замещенные конденсированные гетероциклические с-гликозиды | |
ATE505201T1 (de) | Enzymbehandlung von nahrungsmitteln für zöliakie- sprue | |
ATE506951T1 (de) | Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit | |
DE60026155D1 (de) | Einige alkylendiamin-substituierte heterocyclen | |
MY145077A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
BRPI0508051A (pt) | derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes | |
DK1871374T3 (da) | 2,3-substituerede pyrazinsulfonamider som CRTH2-inhibitorer | |
ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
ATE489948T1 (de) | Behandlung von autoimmunkrankheiten | |
NO20073765L (no) | Forbindelser for behandling av flaviviridae | |
BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
DE60233350D1 (de) | IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES | |
PA8597501A1 (es) | Derivados azabiciclicos de piridiloximetilo y bencisoxazol | |
DE60333205D1 (de) | Histaminika zur behandlung von allergischer rhinitis | |
ATE389439T1 (de) | Behandlung von einschlusskörper-myositis | |
BRPI0511125A (pt) | usos de ácido 5,6,7-triidroxieptanóico seus e análogos | |
EA200701584A1 (ru) | Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения | |
ATE519740T1 (de) | Tetrahydroindolderivate zur behandlung von alzheimer-krankheit | |
ATE423102T1 (de) | 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |